136 related articles for article (PubMed ID: 35538763)
1. [Expression of Glutathione Peroxidases and Its Effect on Clinical Prognosis in Glioma Patients].
Ren XM; Zhang L; Xin B; Qian WW; Xia ZR; Qi M; DU XP; Shi CD; Liu QL; Zhang RQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2022 Apr; 44(2):276-285. PubMed ID: 35538763
[TBL] [Abstract][Full Text] [Related]
2. Glutathione peroxidase family and survival prognosis in patients with renal cell carcinoma.
Li J; Huo S; Zhang R; Shi C; Sun N; Liu Q
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 May; 47(5):562-572. PubMed ID: 35753726
[TBL] [Abstract][Full Text] [Related]
3. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
[TBL] [Abstract][Full Text] [Related]
4. A Bioinformatic Analysis: The Overexpression and Prognostic Potential of
Zhao Q; Zhang L; Wang Y; Sun Y; Wang T; Cao J; Qi M; Du X; Xia Z; Zhang R; Yang Y
Int J Gen Med; 2022; 15():4321-4337. PubMed ID: 35480989
[TBL] [Abstract][Full Text] [Related]
5. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
6. Glutathione Peroxidase
Cueto-Ureña C; Ramírez-Expósito MJ; Mayas MD; Carrera-González MP; Godoy-Hurtado A; Martínez-Martos JM
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761814
[TBL] [Abstract][Full Text] [Related]
7. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
Zhao WJ; Ou GY; Lin WW
Front Immunol; 2021; 12():682415. PubMed ID: 34054873
[TBL] [Abstract][Full Text] [Related]
8. The effects of redox controls mediated by glutathione peroxidases on root architecture in Arabidopsis thaliana.
Passaia G; Queval G; Bai J; Margis-Pinheiro M; Foyer CH
J Exp Bot; 2014 Mar; 65(5):1403-13. PubMed ID: 24470466
[TBL] [Abstract][Full Text] [Related]
9. The Prognostic Role of Glutathione Peroxidase 1 and Immune Infiltrates in Glioma Investigated Using Public Datasets.
Lv S; Luo H; Huang K; Zhu X
Med Sci Monit; 2020 Oct; 26():e926440. PubMed ID: 33085656
[TBL] [Abstract][Full Text] [Related]
10. Exploring the Correlation of Abnormal CXCL9 Expression with Immune Infiltration in Glioma and Patient Prognosis Based on TCGA and GTEx Databases.
Liao Y; Liu B; Jin C; Liao X; Zhang Z
J Mol Neurosci; 2022 Dec; 72(12):2413-2424. PubMed ID: 36449138
[TBL] [Abstract][Full Text] [Related]
11. Identification and validation of a risk model and molecular subtypes based on tryptophan metabolism-related genes to predict the clinical prognosis and tumor immune microenvironment in lower-grade glioma.
Li W; Ling L; Xiang L; Ding P; Yue W
Front Cell Neurosci; 2023; 17():1146686. PubMed ID: 36925967
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel survival prediction model for newly diagnosed lower-grade gliomas.
Zhu Q; Liang Y; Fan Z; Liu Y; Zhou C; Zhang H; He L; Li T; Yang J; Zhou Y; Wang J; Wang L
Neurosurg Focus; 2022 Apr; 52(4):E13. PubMed ID: 35364578
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma.
Zhang M; Wang X; Chen X; Guo F; Hong J
Front Genet; 2020; 11():441. PubMed ID: 32431729
[TBL] [Abstract][Full Text] [Related]
14. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
[TBL] [Abstract][Full Text] [Related]
15. Developing an Immune-Related Signature for Predicting Survival Rate and the Response to Immune Checkpoint Inhibitors in Patients With Glioma.
Zhang S; Xiao X; Wang Y; Song T; Li C; Bao H; Liu Q; Sun G; Sun X; Su T; Fu T; Wang Y; Liang P
Front Genet; 2022; 13():899125. PubMed ID: 35719378
[No Abstract] [Full Text] [Related]
16. Identification and Verification on Prognostic Index of Lower-Grade Glioma Immune-Related LncRNAs.
Wen J; Wang Y; Luo L; Peng L; Chen C; Guo J; Ge Y; Li W; Jin X
Front Oncol; 2020; 10():578809. PubMed ID: 33330055
[TBL] [Abstract][Full Text] [Related]
17. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
[TBL] [Abstract][Full Text] [Related]
18. The overexpression of GPX8 is correlated with poor prognosis in GBM patients.
Li S; Jiang X; Guan M; Zhang Y; Cao Y; Zhang L
Front Genet; 2022; 13():898204. PubMed ID: 36061208
[TBL] [Abstract][Full Text] [Related]
19. A Prognostic Microenvironment-Related Immune Signature
Qiu H; Li Y; Cheng S; Li J; He C; Li J
Front Oncol; 2020; 10():580263. PubMed ID: 33425732
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analyses of the prognosis-related mRNA alternative splicing landscape and novel splicing factors based on large-scale low grade glioma cohort.
Liu WR; Li CY; Xu WH; Liu XJ; Tang HD; Huang HN
Aging (Albany NY); 2020 Jul; 12(13):13684-13700. PubMed ID: 32658870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
